TAILIEUCHUNG - SARCOIDOSIS

Sarcoidosis is one of the best-known systemic granulomatous diseases. Despite intensive investigation, however, the etiology of sarcoidosis has remained unresolved for more than 100 years [1]. Sarcoidosis seems to result from the exposure of a genetically susceptible subject to an environmental agent, and microbial etiologies of sarcoidosis have long been considered based on the clinical similarities to infectious granulomatous diseases [2]. Several epidemio‐ logic mechanisms may underlie the association of an infective agent or agents with the etiology of sarcoidosis, including spatial, seasonal, and occupational clustering [3]. The results of the ACCESS (A Case Control Etiologic Study of Sarcoidosis) study support an association between selected microbially-rich environments and. | SARCOIDOSIS Edited by Yoshinobu Eishi Sarcoidosis http 45958 Edited by Yoshinobu Eishi Contributors Birendra Sah Michael Iannuzzi Yoshinobu Eishi Nagai Luis Jara-Palomares Candelaria Caballero-Eraso Cesar Gutierrez Alvaro Donate Jose Antonio Rodriguez-Portal Lisa Maier Nabeel Hamzeh Watanabe Yuichi Takiguchi Atsushi Kitamura Mohankumar Kurukumbi Preema Mehta Isha Misra Annapurni Jayam Trouth Wakefield Hasib Ahmadzai Paul S. Thomas Morgenthau Akahoshi Andrew Medford Abiramy Jeyabalan Published by InTech Janeza Trdine 9 51000 Rijeka Croatia Copyright 2013 InTech All chapters are Open Access distributed under the Creative Commons Attribution license which allows users to download copy and build upon published articles even for commercial purposes as long as the author and publisher are properly credited which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech authors have the right to republish it in whole or part in any publication of which they are the author and to make other personal use of the work. Any republication referencing or personal use of the work must explicitly identify the original source. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials instructions methods or ideas contained in the book. Publishing Process Manager Marija Radja Technical Editor InTech DTP team Cover InTech Design team First published March 2013 Printed in Croatia A free online edition of this book is available at Additional hard copies can be obtained from orders@ Sarcoidosis Edited by Yoshinobu Eishi p. cm. ISBN 978-953-51-1027-9 INTECH .

• Tiếng Anh thương mại
• Airways Disease
• Clinical Manifestations
• Clinical Features
• Physiological Manifestation
• Pulmonary Sarcoidosis
• Neurosarcoidosis
• BMC Pulmonary Medicine
• Pulmonary function testing
• Forced vital capacity
• Small airways disease
• Prognostic utility
• Respiratory symptoms
• Environmental lung disease
• Hypersensitivity pneumonitis
• Airways diseases
• Miscellaneous infiltrative lung diseases
• Chronic obstructive pulmonary disease
• báo cáo khoa học
• báo cáo y học
• công trình nghiên cứu về y học
• tài liệu về y học
• cách trình bày báo cáo
• trình bày báo cáo
• tài liệu báo cáo khoa học
• công trình nghiên cứu y học
• kiến thức y học
• báo cáo hóa học
• công trình nghiên cứu về hóa học
• tài liệu về hóa học
• nghiên cứu y học
• Acute respiratory distress syndrome
• Blunt chest trauma
• Respiratory physiology
• The chest wall
• Venous thromboembolic disease
• Obstructive airways diseases
• Bacterial infection
• Chronic inflammation of airways
• Acute exacerbations
• Streptococcus pneumoniae
• Chronic inflammatory disease
• Airway hyperresponsiveness
• Allergic asthma
• Immunoglobulin E
• Rheumatoid arthritis
• Obliterative bronchiolitis
• Pulmonary manifestation
• Gastro esophageal reflux disease
• Vagal activity
• Autonomic function testing
• Esophageal acid perfusion
• Obstructive airways disease
• Lung architecture
• Mean linear intercept
• Quantifying morphologic
• Special issue
• Non tuberculous mycobacteria
• Respiratory medicine
• Irreversible airways disease